Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 4, 2019

View Archived Issues

Cyclacel Pharmaceuticals initiates phase I study of CYC-065 plus venetoclax in patients with CLL

Motor protein myosin drives metastasis

Protein links sleep and sickness

SGL-5213 demonstrates efficacy in preclinical model of impaired glucose tolerance

Novel GPR40 superagonist demonstrates remarkable preclinical efficacy in models of diabetes

Preclinical data presented on PBK-001 vaccine for the treatment of melioidosis

Tripartite motif family-like 2 downregulation reduces oral squamous cell carcinoma growth

CSIC patents new PDE8A inhibitors

FDA issues complete response letter for ALKS-5461 NDA for adjunctive treatment of MDD

GenSight announces 48-week data from RESCUE trial of GS-010 in LHON

Dart NeuroScience discloses PDE7B inhibitors

Oxford University signs option agreement with Blue Water Vaccines for universal influenza vaccine

Roche and Genentech identify RIP-1 inhibitors

Nerviano Medical Sciences synthesizes choline kinase inhibitors

Medshine Discovery presents Rho kinase inhibitors

Phosphorylation study gives insights into Chlamydia

OncoSec updates clinical progress with Tavo

Moderna exercises option for exclusive licensing agreement with Avacta

Tinagl1 protein may be therapeutic in triple-negative breast cancer

Circulating miR-3659 found useful for diagnosing dyslipidemia in patients with obesity

FDA clears IND for phase I/IIa trial of VLPM-01 malaria vaccine

BREEZE-AD1 and AD2 studies of baricitinib in atopic dermatitis meet primary endpoints

Eisai plans single phase III confirmatory study of BAN-2401 in early Alzheimer's

Biohaven plans to advance BHV-3500 into phase II for acute treatment of migraine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...